Prognostic Value of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma
Journal of Nuclear Medicine · 2026-06 · 67 (6) · 857-863
DOI: 10.2967/jnumed.125.270727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 26.03.2026. Verfasst von Wietse Geens und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, UZ Brussel, Brussels, Belgium; wietse.geens@uzbrussel.be. Hauptthemen laut MEDLINE: Glioblastoma, Tyrosine, Positron-Emission Tomography, Brain Neoplasms. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, UZ Brussel, Brussels, Belgium; wietse.geens@uzbrussel.be.
- Department of Neurosurgery, UZ Brussel, Brussels, Belgium.
- Department of Nuclear Medicine, UZ Brussel, Brussels, Belgium.
- Department of Medical Oncology, UZ Brussel, Brussels, Belgium; and.
- Department of Electronics and Informatics, Vrije Universiteit Brussel, Brussels, Belgium.
Zitieren
APA
Geens, W., Buyck, F., Raes, L., Schwarze, J. K., Awada, G., De Sutter, S., Bruneau, M., Vandemeulebroucke, J., Everaert, H., Neyns, B., & Duerinck, J. (2026). Prognostic Value of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma. Journal of Nuclear Medicine, 67(6), 857-863. https://doi.org/10.2967/jnumed.125.270727
Vancouver
Geens W, Buyck F, Raes L, Schwarze JK, Awada G, De Sutter S, et al. Prognostic Value of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma. Journal of Nuclear Medicine. 2026;67(6):857-863. doi:10.2967/jnumed.125.270727
BibTeX
@article{Geens2026,
author = {Geens, Wietse and Buyck, Félix and Raes, Laurens and Schwarze, Julia Katharina and Awada, Gil and De Sutter, Selene and Bruneau, Michaël and Vandemeulebroucke, Jef and Everaert, Hendrik and Neyns, Bart and Duerinck, Johnny},
title = {Prognostic Value of O -(2- 18 F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma},
journal = {Journal of Nuclear Medicine},
year = {2026},
volume = {67},
number = {6},
pages = {857--863},
doi = {10.2967/jnumed.125.270727}
}
EUVIMED